BRSBX
Price
$15.85
Change
-$0.08 (-0.50%)
Updated
Jul 31 closing price
Net Assets
318.1M
NAESX
Price
$141.37
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

BRSBX vs NAESX

BRSBX vs NAESX Comparison Chart in %
View a ticker or compare two or three
VS
BRSBX vs. NAESX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRSBX is a Buy and NAESX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 189B vs. BRSBX (318M). NAESX pays higher dividends than BRSBX: NAESX (1.10) vs BRSBX (0.00). BRSBX was incepted earlier than NAESX: BRSBX (11 years) vs NAESX (66 years). BRSBX (1.88) is less costly to investors than NAESX (0.17). BRSBX is a more actively managed with annual turnover of: 66.00 vs. NAESX (17.00). NAESX has a lower initial minimum investment than BRSBX: NAESX (0) vs BRSBX (1000). NAESX annual gain was more profitable for investors over the last year : 22.56 vs. BRSBX (17.06). NAESX return over 5 years is better than : 34.95 vs. BRSBX (-6.93).
BRSBXNAESXBRSBX / NAESX
Total Expense Ratio1.740.171,024%
Annual Report Gross Expense Ratio1.880.171,106%
Fund Existence11 years66 years-
Gain YTD14.19314.56397%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets318M189B0%
Annual Yield % from dividends0.001.10-
Returns for 1 year17.0622.5676%
Returns for 3 years14.9443.3034%
Returns for 5 years-6.9334.95-20%
Returns for 10 years49.11155.2832%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMMSX32.150.39
+1.23%
Vanguard Emerg Mkts Sel Stk Inv
VRGWX936.977.54
+0.81%
Vanguard Russell 1000 Growth Index I
GIDWX20.040.13
+0.65%
Goldman Sachs US Eq Div and Premium R6
CAVAX18.710.04
+0.21%
SEI Catholic Values Equity F (SCVT)
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv